ArticleViruses2026
Co-Infection of PRRSV-1 and PRRSV-2 in a Single Sow: Complete Genome Characterization Reveals a Novel CH-1a-Backbone Recombinant with an NADC30-Derived Nsp2 in China.
Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) has the characteristics of a fast evolution rate and high genetic heterogeneity. PRRSV-1 and PRRSV-2 are co-circulating, and the threat they pose to the health of pigs worldwide continues to rise. In this study, two PRRSV strains with significantly different genetic backgrounds, namely SHEU-2022 (PRRSV-1, full length 15,050 nt) and SHCH-2023 (PRRSV-2, full length 15,019 nt), were simultaneously isolated from a single serum sample of a co-infected sow in Shanghai, China, and their whole-genome characteristics were analyzed. SHEU-2022 clustered with indigenous PRRSV-1 isolates in China, harbored a unique 15-nt deletion in the ORF3-ORF4 overlapping region, carried an additional N-glycosylation site on GP5, and replicated only in porcine alveolar macrophages (PAMs) under the conditions used. SHCH-2023 is a novel recombinant strain with a CH-1a-like (lineage 8) genome backbone and two NADC30-derived fragments-one in Nsp2 (sublineage 1.8) carrying the characteristic 131-amino acid deletion and one in the GP2/E region; it replicated in both PAMs and Marc-145 cells, though this may partly reflect the enrichment procedure. No PRRSV-1/PRRSV-2 recombination was detected between the two co-infected strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.